AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Harmony Biosciences Holdings, Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00WBPG548
36.13▲ 0.10 (0.28%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
36.03
Day's Range
35.00 – 37.05
52-Week Range
25.90 – 43.49
Volume
2.2M
Avg Volume
1.1M
Share Statistics
Shares Outstanding
Employees
293
Exchange
XNAS
Listed
2020-08-19
Share count as of July 31, 2026

Harmony Biosciences Holdings, Inc. Common Stock (HRMY) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Harmony Biosciences Holdings, Inc. Common Stock (HRMY)
What is Harmony Biosciences Holdings, Inc. Common Stock's Market Cap?
Harmony Biosciences Holdings, Inc. Common Stock's Market Cap is $2.1B, based on as-reported figures from SEC (XBRL) filings.
What is Harmony Biosciences Holdings, Inc. Common Stock's Enterprise Value?
Harmony Biosciences Holdings, Inc. Common Stock's Enterprise Value is $1.6B, based on as-reported figures from SEC (XBRL) filings.
What is Harmony Biosciences Holdings, Inc. Common Stock's Trailing P/E?
Harmony Biosciences Holdings, Inc. Common Stock's Trailing P/E is 11.6×, based on as-reported figures from SEC (XBRL) filings.
What is Harmony Biosciences Holdings, Inc. Common Stock's Price / Sales?
Harmony Biosciences Holdings, Inc. Common Stock's Price / Sales is 2.2×, based on as-reported figures from SEC (XBRL) filings.
What is Harmony Biosciences Holdings, Inc. Common Stock's EV / Revenue?
Harmony Biosciences Holdings, Inc. Common Stock's EV / Revenue is 1.7×, based on as-reported figures from SEC (XBRL) filings.
What is Harmony Biosciences Holdings, Inc. Common Stock's EV / EBITDA?
Harmony Biosciences Holdings, Inc. Common Stock's EV / EBITDA is 6.2×, based on as-reported figures from SEC (XBRL) filings.
What is Harmony Biosciences Holdings, Inc. Common Stock's Revenue (TTM)?
Harmony Biosciences Holdings, Inc. Common Stock's Revenue (TTM) is $959.9M, based on as-reported figures from SEC (XBRL) filings.
What is Harmony Biosciences Holdings, Inc. Common Stock's Net Income (TTM)?
Harmony Biosciences Holdings, Inc. Common Stock's Net Income (TTM) is $181.3M, based on as-reported figures from SEC (XBRL) filings.
What is Harmony Biosciences Holdings, Inc. Common Stock's EBITDA?
Harmony Biosciences Holdings, Inc. Common Stock's EBITDA is $254.5M, based on as-reported figures from SEC (XBRL) filings.
What is Harmony Biosciences Holdings, Inc. Common Stock's Diluted EPS (TTM)?
Harmony Biosciences Holdings, Inc. Common Stock's Diluted EPS (TTM) is 3.11, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · HRMYAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
Net product revenue
YoY growth+30.3%+16.6%+21.1%+28.7%
Cost of product sold
Gross profit
% of revenue75.8%79.3%71.9%75.1%
Operating expenses:
Research and development
Sales and marketing
General and administrative
Total operating expenses
% of revenue41.6%62.0%56.1%47.7%
Operating income
% of revenue34.2%17.3%15.8%27.3%
Other expense, net
Interest expense
Interest income
Income before income taxes
Income tax expense
Net income
% of revenue28.9%15.1%9.2%21.2%
Basic (in dollars per share)
Diluted (in dollars per share)